BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 689827)

  • 1. Time-related contrast enhancement of blood, normal muscle, and V2 carcinoma in the rabbit as determined by CT scanning.
    Young SW; Rumbaugh CL
    Invest Radiol; 1978; 13(4):334-6. PubMed ID: 689827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography of rabbit V2 carcinoma after intraarterial contrast enhancement.
    Young SW; Enzmann D; Marglin SI
    J Comput Assist Tomogr; 1979 Apr; 3(2):185-8. PubMed ID: 429626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast enhancement of malignant tumors after intravenous polyvinylpyrrolidone with metallic salts as determined by computed tomography.
    Young SW; Muller HH; Marincek B
    Radiology; 1981 Jan; 138(1):97-105. PubMed ID: 7455104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT contrast enhancement of kidney V2 carcinoma after norepinephrine and acetylcholine injection.
    Marincek B; Muller HH; Young SW
    Invest Radiol; 1981; 16(6):487-90. PubMed ID: 7319754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compromised CT detection of extracranial malignant neoplasms by steroid treatment.
    Marincek B; Young SW; Muller HH; Enzmann DR
    J Comput Assist Tomogr; 1981 Aug; 5(4):491-5. PubMed ID: 7263987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.
    Young SW; Turner RJ; Castellino RA
    Radiology; 1980 Oct; 137(1 Pt 1):137-47. PubMed ID: 7422835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiographic blood pool contrast agents for vascular and tumor imaging with projection radiography and computed tomography.
    Cassel DM; Young SW; Brody WR; Muller HH; Hall AL
    J Comput Assist Tomogr; 1982 Feb; 6(1):141-6. PubMed ID: 6279714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved detectability of VX2 carcinoma in the rabbit liver with contrast enhancement in computed tomography.
    Violante MR; Dean PB
    Radiology; 1980 Jan; 134(1):237-9. PubMed ID: 7350611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast enhancement dynamic CT measurements and a mathematical model.
    Cassel DM; Young SW; Turner R
    Invest Radiol; 1982; 17(1):82-9. PubMed ID: 7076440
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT.
    Freeny PC; Marks WM
    Radiology; 1986 Sep; 160(3):613-8. PubMed ID: 3016794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluoroctylbromide contrast enhancement of malignant neoplasms: preliminary observations.
    Young SW; Enzmann DR; Long DM; Muller HH
    AJR Am J Roentgenol; 1981 Jul; 137(1):141-6. PubMed ID: 6787865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast enhancement of focal hepatic lesions in CT: effect of size and histology.
    Burgener FA; Hamlin DJ
    AJR Am J Roentgenol; 1983 Feb; 140(2):297-301. PubMed ID: 6600347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CT evaluation of extravascular perfusion of contrast medium and its potential to a new method of diagnosis: an experimental study using macro, micro-molecular contrast media].
    Sako M; Sugimoto K; Matsumoto S; Hirota S; Fujita Y; Hasegawa Y; Kuwata Y; Tomita M; Murakami T; Kono M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):289-91. PubMed ID: 8177705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast media in body computed tomography: experimental and theoretical background background, present limitations, and proposals for improved diagnostic efficacy.
    Dean PB
    Invest Radiol; 1980; 15(6 Suppl):S164-9. PubMed ID: 7203918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous contrast enhancement in computed tomography of pelvic malignancies.
    Burgener FA; Hamlin DJ
    Rofo; 1981 Jun; 134(6):656-61. PubMed ID: 6454627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed enhanced CT of lipid-poor adrenal adenomas.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Dunnick NR
    AJR Am J Roentgenol; 2000 Nov; 175(5):1411-5. PubMed ID: 11044054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer imaging by scanned projection radiography.
    Cassel DM; Young SW; Brody WR; Hall AL
    J Comput Assist Tomogr; 1981 Aug; 5(4):557-62. PubMed ID: 7263995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
    Ma X; Samir AE; Holalkere NS; Sahani DV
    AJR Am J Roentgenol; 2008 Sep; 191(3):772-7. PubMed ID: 18716108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary study of indirect CT lymphography-guided sentinel lymph node biopsy in a tongue VX2 carcinoma model.
    Wu H; Xu X; Ying H; Hoffman MR; Shen N; Sha Y; Zhou L
    Int J Oral Maxillofac Surg; 2009 Dec; 38(12):1268-72. PubMed ID: 19679448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of patient weight and scanning duration on contrast enhancement during pulmonary multidetector CT angiography.
    Bae KT; Tao C; Gürel S; Hong C; Zhu F; Gebke TA; Milite M; Hildebolt CF
    Radiology; 2007 Feb; 242(2):582-9. PubMed ID: 17255426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.